Merck KGaA, Darmstadt, Germany: Belén Garijo Receives Prestigious Career Award
- Award from non-profit Spanish foundation Fundamed recognizes most influential pharmaceutical executive from Spain over the past 15 years
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that Belén Garijo, Member of the Executive Board and CEO Healthcare, has received a special career-recognition award from the Fundamed Foundation in Madrid, Spain. Fundamed is a Spanish non-profit foundation established in 2001 whose main objective is to promote biomedical research and patient organization participation in health policy-making at all levels.
During the presentation of the award, Enrique Sánchez de León Pérez, former Health Minister in Spain and President of Fundamed, said, “As the Fundamed Foundation awards are celebrating their 15th birthday, we wanted to recognize the most influential Spanish pharmaceutical executive over the past 15 years with a special award. The board was of the unanimous opinion that this special award should go to Belén Garijo, not only because she is the most successful pharmaceutical executive with one the most extensive and comprehensive international careers that Spain has ever seen, but most importantly because her success is built on strong values and ethics, always putting patients’ interests first.”
“I am honored to receive the prestigious Fundamed award and grateful for this recognition. Offering value to patients and customers has been both a major goal and a continuous stimulus throughout my professional career,” said Garijo. “Having worked for many companies over my career, I can now say that I am particularly proud to work for my current employer because as a company we bring great value to individual patients, healthcare professionals and society.”
This special award was decided by Fundamed’s Board of Trustees composed of Enrique Sánchez de León, Santiago de Quiroga, Fundamed Vice-President, Vicente Díaz Sagredo, Fundamed Trustee, and Jesus Díaz Olmo, Secretary of the Fundamed Board.
During Garijo’s career of nearly 30 years in the pharmaceutical industry, she has held positions with Abbott Laboratories and Sanofi in a number of countries. She joined Merck KGaA, Darmstadt, Germany, in 2011 as Chief Operating Officer, was promoted to Chief Executive Officer of the Biopharma business in 2013 and was appointed member of the Executive Board and CEO of the Healthcare business sector of Merck KGaA, Darmstadt, Germany, in 2015 (for her full CV please click here).
Garijo, a Spanish citizen residing in Germany and one of few women in top executive positions among Germany’s blue-chip companies, was recently acknowledged by a leading German publication as a “Top 50 Woman Leader in Germany”. Merck KGaA, Darmstadt, Germany, sees an open corporate culture and a diverse workforce as substantial contributors to its business success. Therefore, promoting diversity and inclusion as well as making employees more willing to embrace cultural change are special areas of emphasis of Human Resources work at Merck KGaA, Darmstadt, Germany, extending from the top management level throughout the entire workforce.
Fundamed - Science Medicine and Health Products Foundation - is an organization formed and supported by important companies in the Spanish health sector, experts and scientists. It was founded in 2001 in a complex environment of significant changes affecting the global pharmaceutical sector in general and the Spanish one in particular.
Currently, Fundamed encourages initiatives around research and development and patient advocacy associations and the sustainability of the health sector in Spain.
With its awards, Fundamed recognizes organizations, pharmaceutical companies, institution and personalities whose roles have been relevant in the healthcare sector. This year, Fundamed awards are celebrating their 15th edition.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck" name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Merck KGaA, Darmstadt, Germany, has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.